The Food and Drug Administration intends to award a non-competitive, sole source purchase order to ATG Laboratories Inc., Eden Prairie, MN. ATG Laboratories, Inc. shall continue to provide expertise in areas which include: a. producing, quantifying, and plaque purifying baculovirus; b. scalingsuccessful baculovirus recombinants for large scale protein expression; and c. producing synthetic genes according to our design for efficient expression of proteins using codon optimization. These functions are essential for FDA’s research program. This is not a request for quotes. However, evaluation of award will be based on the technically acceptable quote that offers the best value to the government. The FDA intends to make an award immediately after the response date of this notice. The sole source procurement is being awarded as a simplified acquisition in accordance with FAR Subpart 13.5.

Bid Protests Not Available